Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform GlobeNewswire - Mon Mar 2, 6:00AM CST

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be...

RPRX : 45.41 (-0.59%)
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing GlobeNewswire - Mon Mar 2, 5:10AM CST

Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaid Zymeworks to retain...

RPRX : 45.41 (-0.59%)
ZYME : 24.08 (-2.90%)
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing GlobeNewswire - Mon Mar 2, 5:01AM CST

Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaid Zymeworks to retain...

RPRX : 45.41 (-0.59%)
ZYME : 24.08 (-2.90%)
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference GlobeNewswire - Thu Feb 26, 3:15PM CST

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 46 th Annual Health Care Conference on March...

RPRX : 45.41 (-0.59%)
MTD
3 Healthcare Stocks Walking a Fine Line StockStory - Wed Feb 18, 10:37PM CST

3 Healthcare Stocks Walking a Fine Line

RPRX : 45.41 (-0.59%)
MTD : 1,209.65 (-4.09%)
RVTY : 91.34 (-5.42%)
RPRX
5 Insightful Analyst Questions From Royalty Pharma’s Q4 Earnings Call StockStory - Tue Feb 17, 11:38PM CST

5 Insightful Analyst Questions From Royalty Pharma’s Q4 Earnings Call

RPRX : 45.41 (-0.59%)
RPRX
Royalty Pharma (NASDAQ:RPRX) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings StockStory - Wed Feb 11, 6:25AM CST

Royalty Pharma (NASDAQ:RPRX) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings

RPRX : 45.41 (-0.59%)
Royalty Pharma Reports Q4 and Full Year 2025 Results GlobeNewswire - Wed Feb 11, 6:00AM CST

Portfolio Rece ipts of $874 million in Q4 2025 and $3,254 million for FY 2025 Portfolio Receipts growth of 18% in Q4 2025 and 16% for FY 2025 Net cas h provided by operating activities of...

RPRX : 45.41 (-0.59%)
RPRX
What To Expect From Royalty Pharma’s (RPRX) Q4 Earnings StockStory - Mon Feb 9, 9:06PM CST

What To Expect From Royalty Pharma’s (RPRX) Q4 Earnings

RPRX : 45.41 (-0.59%)
RPRX
3 Mid-Cap Stocks We Keep Off Our Radar StockStory - Thu Feb 5, 10:38PM CST

3 Mid-Cap Stocks We Keep Off Our Radar

RPRX : 45.41 (-0.59%)
IFF : 73.77 (-2.14%)
NLY : 22.41 (-2.44%)

Barchart Exclusives

1 Little-Known Tech Stock That Wedbush Calls a Must-Own Amid Middle East Conflict Barchart - Sat Mar 7, 10:30AM CST
Check Point emerges as a must-own cybersecurity stock amid Middle East tensions, offering stable AI-driven growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot